Sign inJoin waitlistJoin the waitlist

Sameer Parikh

Associate Professor of Medicine · Mayo Clinic College of Medicine and Science

Credentials: · · · ·

History

Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Hematology
2004–2005
Internal Medicine
2001–2004
Bachelor of Medicine, Bachelor of Surgery
1997–2001

Research

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
New England Journal of Medicine · 2018 · 782 citations
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Cancer Discovery · 2016 · 430 citations
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Blood · 2017 · 361 citations

Neil Kay
103 papers
TC
Timothy Call
76 papers
WD
Wei Ding
67 papers
Tait Shanafelt
61 papers · 27 as a fellow
JL
Jose Leis
48 papers
Paul Hampel
42 papers · 17 as a resident
Curtis Hanson
37 papers
Yucai Wang
32 papers · 5 as a fellow
EM
Eli Muchtar
30 papers
Amber Koehler
27 papers
MS
Min Shi
21 papers
Asher Chanan-Khan
18 papers

Grants

Paradigm Shift in the Management of Patients with Previously Untreated Chronic Lymphocytic Leukemia Through NCI-Sponsored Clinical Trials
National Cancer Institute · R50
Contact PI · $372.7K · Mayo Clinic Rochester
2024–2029

Clinical trials

Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies
Principal investigator · Completed
Mayo Clinic
2021–2022
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
Principal investigator · Withdrawn · Phase 2
Academic and Community Cancer Research United
2020–2022
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Principal investigator · Recruiting · Phase 2
Mayo Clinic
2018–2030
Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
Principal investigator · Terminated
Mayo Clinic
2017–2025